CMAB009
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CMAB009, covering 2019-04-10 to 2025-05-23. Get the full timeline:
Most recent: Clinical Trial Update: CMAB009 Combined With FOLFIRI First-line Treatment in Patients With RAS/BRAF Wild-type, Metastatic Colorectal Cancer [Phase 3]